In situ local administration of PQ912 via an injectable hydrogel down-regulated the expression of CD47 on the tumor surface and enhanced the function of antigen-presenting cells, thereby stimulating T cell-mediated antitumor immunity (Figure 1). The gene discussed is CD47; the disease is neoplasm.